Location:

Local - Houston Metro

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Breast Cancer, ER-positive breast cancer, Retinoblastoma Protein, Cyclin E

Study Shows Biomarkers Can Predict Which ER-Positive Breast Cancer Patients Respond Best to First-Line Therapy

Keyomarsi.jpg

Two challenges in treating patients with estrogen-positive breast cancer (ER+) have been an inability to predict who will respond to standard therapies and adverse events leading to therapy discontinuation. A study at The University of Texas MD Anderson Cancer Center revealed new information about how the biomarkers retinoblastoma protein (Rb) and cytoplasmic cyclin E could indicate which patients will respond best to current first-line therapies.

Medicine

Channels:

Retinitis Pigmentosa, hispanic health disparities, Hispanic, southwestern united states, Eye Disease, Genetics

Gene Mutation Linked to Retinitis Pigmentosa in Southwestern U.S. Hispanic Families

stephen-daiger-2012-web.jpg

Thirty-six percent of Hispanic families in the U.S. with a common form of retinitis pigmentosa got the disease because they carry a mutation of the arrestin-1 gene, according to a new study from researchers at The University of Texas Health Science Center at Houston (UTHealth) School of Public Health.

Life

Education

Channels:

The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences at Houston, The University of Texas Health Science at Houston (UTHealth), The University of Texas MD Anderson Cancer Center, John Kopchick, Charlene Kopchick, SOMAVERT, Gigantism

With $10.5 Million Gift to MD Anderson UTHealth Graduate School, Ohio Couple Paves Way for Future Scientists

Dr.JohnandCharKopchick_Daydebfaveposting1-6.jpg

Just as he has changed the lives of people suffering from a devastating genetic disease, molecular endocrinologist John J. Kopchick, Ph.D., and his wife, Charlene, of Athens, Ohio, are paving the way for future scientists to do the same with a transformative $10.5 million gift to The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences.

Medicine

Channels:

MD Anderson Cancer Center, UTHealth , The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences at Houston

MD Anderson UTHealth Graduate School Receives $10.5 Million Gift

GSBSlogo.png

Just as he has changed the lives of people suffering from a devastating genetic disease, molecular endocrinologist John J. Kopchick, Ph.D., and his wife, Charlene, of Athens, Ohio, are paving the way for future scientists to do the same with a transformative $10.5 million gift to The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences.

Medicine

Channels:

UTHealth

UTHealth’s Lenard Lichtenberger Tests Effectiveness of Lipidic Aspirin Formulation Against Cancer

LenardLichtenberger.jpg

Scientists at The University of Texas Health Science Center at Houston (UTHealth) are testing the effectiveness of a soy-enriched aspirin formulation designed to fight colorectal cancer with fewer side effects.

Medicine

Channels:

Cancer, CEO Cancer Gold Standard, Employee Health, Healthy Behavior

Harris Health Named CEO Cancer Gold Standard™ Employer Five Years in a Row

Harris Health System has earned the CEO Cancer Gold Standard™ for the fifth straight year for its efforts to reduce the risk of cancer for its employees and covered family members.

Medicine

Channels:

Medicare, Medicaid, Harris County, Houston, UTHealth , Public Health, community health workers

UTHealth School of Public Health Awarded $2.6 Million to Address Social Needs of Medicare and Medicaid Beneficiaries in Harris County

Researchers at The University of Texas Health Science Center at Houston (UTHealth) School of Public Health have received a nearly $2.6 million grant for an innovative project that will address the social factors that affect the health of Medicare and Medicaid beneficiaries in Harris County.

Medicine

Channels:

UTHealth , UTHealth Medical School, McGovern Medical School

UTHealth a Site for First-Ever Large NIDA Trial for Methamphetamine Use Disorder

Schmitz_1.jpg

With the rates of methamphetamine use reaching an all-time high in Texas, raising alarms for the Greater Houston area, McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth) researchers have launched a clinical trial to study a combination of medications designed to treat methamphetamine use disorder.

Medicine

Channels:

MD Anderson and Convergent R.N.R. Ltd. Establish Alliance to Further Develop New Radiation Technology with Potentially Fewer Side Effects

The University of Texas MD Anderson Cancer Center and Convergent R.N.R. Ltd. (CRnR) today announced a collaboration to further develop new radiation technology aimed at reducing side effects of standard radiation including unwanted radiation to healthy tissue.

Medicine

Channels:

Pancreatic Cancer, KRAS, Exosome, Cancer Biology, Cancer Biology & Therapy

Innovative Therapy Strategy for Pancreatic Cancer Uses Engineered Exosomes Targeting Mutated KRAS Gene

LeBleu_V.jpg

Genetic manipulation of exosomes, virus-sized particles released by all cells, may offer a new therapeutic approach to treating pancreatic cancer, according to a study at The University of Texas MD Anderson Cancer Center.







Chat now!